Clinical trial
Continuous Subcutaneous Infusion of Pramlintide and Insulin: A Randomized, Crossover Design Study
NCT00291772 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Continuous Subcutaneous Infusion of Pramlintide and Insulin: A Randomized, Crossover Design Study
- Lead sponsor
- Baylor College of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- November 30, 2007
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes